Showing results (371-380 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|March 1, 1994
Intraarterial combined immunochemotherapy for unresectable hepatocellular carcinoma: preliminary resultsM Oka, S Hazama, S Yoshino, et al.Cancer Immunology, Immunotherapy : CII|March 1, 1994
Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell inductionD W Hoskin, T Reynolds, J BlayCancer Immunology, Immunotherapy : CII|November 1, 1993
Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cellsD S Hoon, Y Hayashi, T Morisaki, et al.Cancer Immunology, Immunotherapy : CII|November 1, 1993
Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiationY Umezu, L B Augustus, D Seito, et al.Cancer Immunology, Immunotherapy : CII|November 1, 1993
Effect of Adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expressionT Asano, W Fujimaki, A McWatters, et al.Cancer Immunology, Immunotherapy : CII|January 6, 2010
Regulation of immunity and oncogenesis by the IRF transcription factor familyDavid Savitsky, Tomohiko Tamura, Hideyuki Yanai, et al.Cancer Immunology, Immunotherapy : CII|November 19, 2009
A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vectorW Zhang, T Zhang, M-J Turk, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1993
Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodiesG D Lewis, I Figari, B Fendly, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell functionR A Rasmussen, S L Counts, J M Lambert, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
T lymphocyte killing by a xanthine-oxidase-containing immunotoxinM G Battelli, A Abbondanza, P L Tazzari, et al.Pageof 650